Entrepreneurship

Challenges in the Gene Therapy Commercial Ecosystem

Print Share
The emergence of biotech has resulted in a rich ecosystem of different types of actors contributing to the technological advance. Despite the enormous promise of biotech-based therapeutics, there is substantial uncertainty regarding when scientific discoveries will emerge, whether these discoveries will achieve clinical success, and how commercialized treatments will create value. Here we shed light on two contrasting episodes of technological advance, in monoclonal antibodies (mAbs) and gene therapy, and the roles played by different types of institutional actors from the 1990s to today.
Bibliographic citation: Kapoor, Rahul; Klueter, Thomas Maximilian; Wilson, James M., "Challenges in the Gene Therapy Commercial Ecosystem", Nature Biotechnology, Vol. 35, No. 9, 2017, pp 813 - 815

Reference: 10.1038/nbt.3931 (DOI)
Date: 11/09/2017
Author(s): Kapoor, Rahul; Klueter, Thomas Maximilian; Wilson, James M.
Document type: Article in Journal (refereed)
Languages: English